STAT Plus: AbbVie pays $24 million to settle lawsuit over using ‘nurse ambassadors’ to boost Humira sales
After two years of wrangling, AbbVie (ABBV) agreed to pay $24 million to settle a…
Category: Pharmalot
STAT Plus: Italy becomes first country to require pharma to disclose public funding for R&D costs
Amid growing clamor for more transparency from the pharmaceutical industry, Italy has become the first…
STAT Plus: Pressure mounts on FDA chief to stick with science for Covid-19 vaccine approvals
As pressure mounts to develop a successful Covid-19 vaccine, Food and Drug Administration Commissioner Stephen…
STAT Plus: Pharmalittle: AstraZeneca strikes first Covid-19 deal with a Chinese company; vaccine trials face distrust from minority groups
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Pharmalittle: J&J to supply U.S. with 100 million Covid-19 vaccine doses; Feds seek $18 billion from Purdue in opioid probe
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT Plus: State attorneys general urge HHS to sidestep Gilead patents to increase remdesivir access
A bipartisan group of state attorneys general is urging the federal government to sidestep the…
STAT Plus: BARDA faces pressure to force Moderna to disclose cost details from its Covid-19 contract
Amid concerns over U.S. government Covid-19 contracts and transparency, Moderna (MRNA) has failed to comply…
STAT Plus: Pharmalittle: Regeneron Covid-19 antibody treatment works in animals; Warren asks SEC to probe Kodak trading
Top of the morning to you, and a fine one it is. Despite a looming…
STAT Plus: Prescription drugs may be more affordable than you think — unless you pay cash
Amid growing complaints that many Americans cannot afford their prescription medicines, most people in the…
STAT Plus: Gilead faces renewed pressure to pursue remdesivir-like compound to fight Covid-19
In an unusual move, a pair of academics is escalating an effort to convince Gilead…
STAT Plus: Justice Department probes Sanofi and GlaxoSmithKline over possible carcinogen in Zantac pills
The Department of Justice has started investigating whether drug makers failed to disclose information about…
.jpg)
STAT Plus: Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Music in drug ads makes it easier for the public to tune out side effects, advocates argue
This will not be music to the ears of the pharmaceutical industry. A pair of…
STAT Plus: In a blow to Catalyst, judge recommends tossing its lawsuit against FDA
A federal court judge recommended tossing out a lawsuit filed by Catalyst Pharmaceuticals (CPRX) that…
STAT Plus: Pharmalittle: U.S. hands Glaxo and Sanofi $2.1 billion for a Covid-19 vaccine; Moderna director resigns over conflict concerns
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Drug makers build Covid-19 vaccine supply chains; VCs are still spending on biotechs
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT Plus: Drug maker settles charges of offering ‘bogus’ research grants to boost use of its medicine
In the latest imbroglio involving drug makers and kickbacks, Pacira Biosciences (PCRX) has agreed to…
STAT Plus: Seeking to battle high drug prices and the opioid crisis, two states ponder banning gifts to doctors
Over the past month, lawmakers in two states have introduced bills that would ban drug…
STAT Plus: Pharmalittle: Global supply chain not ready for Covid-19 vaccines; Moderna may price its vaccine at up to $60
Good morning, everyone, and welcome to the middle of the week. You made it this…
STAT Plus: Cepheid is accused of overcharging and undersupplying its Covid-19 test to poor countries
As controversy rises over equal access to Covid-19 medical products, a manufacturer of rapid, point-of…
STAT Plus: Lawmakers urge federal watchdog to probe government’s role in discovering remdesivir
Amid concerns over access to medicines that were hatched with U.S. taxpayer funds, Democratic lawmakers…
STAT Plus: Pharmalittle: Pharma execs nix meeting with Trump; Kodak wins big U.S. loan to fix medical supply chain
Hello, everyone, and how are you today? We are doing reasonably well, given the circumstances….
STAT Plus: New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug
A New York State panel has recommended that officials seek a supplemental Medicaid rebate for…
STAT Plus: Generic group fails again to block California law that bans pay-to-delay deals
A federal appeals court denied a bid by a pharmaceutical industry trade group to block…
STAT Plus: Pharmalittle: Moderna gets $472 million as late-stage Covid-19 vaccine trial begins; EU turns away from WHO vaccine effort
Good morning, everyone, and nice to see you again. We have returned, so to speak,…
STAT Plus: Pharmalittle: Moderna loses a key patent decision; China says its Covid-19 vaccine will be ready this year
Good morning and happy Friday. Elizabeth Cooney here, thinking of the vacationing Ed Silverman’s weekly…
STAT Plus: Pharmalittle: NIH launching ‘flurry’ of Covid-19 treatment trials; Pfizer-BioNTech deal sets ceiling for vaccine price
Good morning. Elizabeth Cooney here, filling in for Ed Silverman until he returns from vacation…
STAT Plus: Pharmalittle: U.S. to pay $1.95b for Pfizer-BioNTech Covid-19 vaccine; who decides who gets the first doses?
Good morning. Elizabeth Cooney here, channeling the vacationing Ed Silverman’s Wednesday wisdom: We’ve made it…
STAT Plus: Pharmalittle: Covid-19 vaccines may need two doses; lawmakers grilling pharma execs own their stocks
Good morning. Elizabeth Cooney here again, subbing for the vacationing Ed Silverman as the week…
STAT Plus: Pharmalittle: U.K. inks coronavirus vaccine deal; Synairgen says its drug lowers Covid-19 risk
Good morning. Elizabeth Cooney here in Boston, sitting in for Ed Silverman, who’s on holiday…
STAT Plus: Pharmalittle: Hydroxychloroquine fails once more; Russian hackers target coronavirus vaccine data
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
STAT Plus: Novartis to provide drugs for Covid-19 patients at no cost, but fails to disclose pricing
As companies face pressure to ensure access to medicines during the pandemic, Novartis (NVS) plans…
STAT Plus: Pharmalittle: Warp Speed chief can avoid ethics disclosures; China OKs a BioNTech Covid-19 vaccine trial
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Pharmalittle: Moderna vaccine is a ‘good beginning’; hospitals stock up on drugs for Covid-19
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
.jpg)
STAT Plus: AbbVie uses dozens of patents to ward off competition for a pricey cancer medicine
The pricey Imbruvica cancer treatment that became available seven years ago could have its monopoly…
STAT Plus: Drug maker offers to slash prices on cancer medicines to end European price gouging probe
In response to a probe into alleged price gouging, Aspen Pharma has agreed to slash…
STAT Plus: Sun Pharma employee says she was fired for complaining that samples were improperly shipped
A former Sun Pharmaceutical sales rep filed a lawsuit arguing she was fired from her…
STAT Plus: Ohio sues Express Scripts for ‘egregiously’ overcharging for medicines
The Ohio Attorney General has filed a lawsuit alleging Express Scripts overcharged a state pension…
STAT Plus: Pharmalittle: Pharma ramps up clinical trials after Covid-19 delays; skepticism high over vaccine profits and global distribution
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT Plus: European Parliament backs WHO effort to create a Covid-19 technology access pool
In an overwhelming vote, the European Parliament late last week voted to support a World…
STAT Plus: Pharma trade group scolds Gilead again for misleading information about a rival HIV drug
For the second time in less than two years, Gilead Sciences (GILD) has been reprimanded…
STAT Plus: Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: How can cancer drug prices better match their benefits? Germany offers a cost-saving model
A new study finds that after Germany revamped its approach to purchasing medicines a decade…
STAT Plus: Pharmalittle: BioNTech expects to seek approval for vaccine by year-end; why the FDA chose a 50% threshold for Covid-19 vaccines
And so, another working week will soon draw to a close. Not a moment too…
Despite the pandemic, prices for many drugs keep rising
Despite the economic hardships the Covid-19 pandemic has created for many Americans, drug makers raised…
STAT Plus: Two dozen big drug makers launch a $1 billion fund to develop new antibiotics
In response to heightened concerns over antibiotic resistance, two dozen of the world’s largest pharmaceutical…
STAT Plus: Pharmalittle: Gilead to boost remdesivir supplies in Europe; drug makers announcing $1 billion antibiotic innovation fund
Good morning, everyone, and welcome to another busy day. You made it this far this…
The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says
Earlier this week, a Canadian company called Medicago struck two deals to supply its plant-based…
STAT Plus: Pharmalittle: Will a coronavirus vaccine be budget-breaking? Europe has deals with Merck and Roche for Covid-19 drugs
Rise and shine, another busy day is on the way. We can tell because the…
STAT Plus: Did a pharma trade group try to sabotage a Dutch government report on compulsory licensing?
A Dutch government commission on compulsory licensing was nearly sabotaged last month after one of…